Therapeutic compositions to improve the effect of the...

Details Therapeutic compositions to improve the effect of the... Therapeutic compositions to improve the effect of the...

A - Human Necessities

61

K

A61K 39/395 (2006.01) A61K 38/21 (2006.01)

Patent

CA 2664795

The present invention describes specific therapeutic compositions which increase the effectiveness of monoclonal antibody (mAb) therapy against the epidermal growth factor receptor (EGFR) and type-I (.alpha./ß) interferons (IFNs).

Cette invention concerne des compositions thérapeutiques spécifiques augmentant l'efficacité de la thérapie aux anticorps monoclonaux (AcMs) contre le récepteur du facteur de croissance épidermique (EGFR, de l'anglais "epidermal growth factor receptor") et des interférons (INFs) de type I (.alpha./ß).

Affiliated with

Also associated with

Rating

Therapeutic compositions to improve the effect of the... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Therapeutic compositions to improve the effect of the..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Therapeutic compositions to improve the effect of the... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1388281